tafamidis meglumine Inhibitor

Tafamidis meglumine is a Potent and Selective Transthyretin Kinetic Stabilizer That Inhibits the Amyloid Cascade

Bulawa C E, Connelly S, Devit M, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade[J]. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(24):p.9629-9634.
Bulawa C E, Connelly S, Devit M, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade[J]. Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(24):p.9629-9634.
Tafamidis treatment, for Patients with Transthyretin Amyloid Cardiomyopathy.[J]. The New England journal of medicine, 2018.
Tafamidis treatment, for Patients with Transthyretin Amyloid Cardiomyopathy.[J]. The New England journal of medicine, 2018.

Small volumes of tafamidis meglumine, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5758474 is an inhibitor targeting tafamidis meglumine.